FormWeb • fosaprepitant

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

fosaprepitant

fosaprepitant

Restricted Emend for Injection --> Restricted to no sub oncology physician use.
Restricted Miscellaneous Program Formulary

Drug Name	Form	Strength
Cinvanti	EMULSION, INTRAVENOUS	130 mg/18 mL
Emend for Injection	POWDER FOR INJECTION, INTRAVENOUS	115 mg
Emend for Injection	POWDER FOR INJECTION, INTRAVENOUS	150 mg

VIEW MORE Antiemetics, Miscellaneous
CLASS

Comments:

Therapeutic Interchange for Adults

fosaprepitant (Emend for Injection)

HEC:
- 150 mg IV over 20-30 min. Approximately 30 min. before chemo
MEC:
- 150 mg IV over 20-30 min. Approximately 30 min. before chemo

aprepitant (Cinvanti)

HEC:
- 130 mg IVP over 2 min. Approximately 30 min. before chemo
MEC:
- 130 mg IV over 2 min. Approximately 30 min. before chemo

Fosaprepitant (Emend IV) / Cinvanti Formulary Interchange/Restrictions

Fosaprepitant is considered formulary restricted to oncology for use in adults and pediatrics both inpatient and outpatient for the prevention of CINV. For adults, both fosaprepitant and Cinvanti will be approved per formulary policy for adult use in CINV, restricted to Oncology, and the selection of product will depend on cost-effectivenesss for the time period, specific setting, or patient situation. The pharmacist may interchange fosaprepitant 150 mg and Cinvanti 130 mg as appropriate per above statement.The 115 mg regimen (which must be followed by 2 days of oral aprepitant therapy) is classified as non-formulary, not stocked.

Reviewed: June 24, 2008 (115 mg regimen) and March 22, 2011 (150 mg regimen), and 27 Feb 2018 (Interchange), and March 25 2020 (Interchange)

Last updated: Mar. 26, 2020

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.